Postes actifs de Jean-Paul Renaud
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Urania Therapeutics SAS
 Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Directeur/Membre du Conseil | 01/10/2015 | - |
| Directeur Technique/Scientifique/R&D | 01/10/2015 | - | |
| Fondateur | 01/10/2015 | - | |
| President | 01/10/2015 | - |
Historique de carrière de Jean-Paul Renaud
Anciens postes connus de Jean-Paul Renaud
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
NovAliX SAS
 NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Directeur Technique/Scientifique/R&D | 01/01/2002 | - |
| Fondateur | 01/01/2002 | - |
Statistiques
Internationale
| France | 3 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
NovAliX SAS
NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France. | Health Technology |
Urania Therapeutics SAS
Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Health Technology |
- Bourse
- Insiders
- Jean-Paul Renaud
- Expérience
